Cibc World Market Inc. Amgen Inc Transaction History

Cibc World Market Inc.

$43.4 Billion
Q2 2024

A detailed history of Cibc World Market Inc. transactions in Amgen Inc stock. As of the latest transaction made, Cibc World Market Inc. holds 95,173 shares of AMGN stock, worth $31.7 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

95,173

Previous 107,595 11.55%

Holding current value

$31.7 Million

Previous $30.6 Million 2.79%

% of portfolio

0.07%

Previous 0.07%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$262.75 - $319.31 $3.26 Million - $3.97 Million	-12,422 Reduced 11.55%	95,173 $29.7 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $7.53 Million - $9.09 Million	27,992 Added 35.16%	107,595 $30.6 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $2.79 Million - $3.15 Million	-10,917 Reduced 12.06%	79,603 $22.9 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $1.3 Million - $1.62 Million	5,954 Added 7.04%	90,520 $24.3 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $3.64 Million - $4.3 Million	-16,986 Reduced 16.73%	84,566 $18.8 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $1.45 Million - $1.76 Million	-6,408 Reduced 5.94%	101,552 $24.6 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $920,013 - $1.17 Million	-4,017 Reduced 3.59%	107,960 $28.4 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $1.88 Million - $2.12 Million	8,384 Added 8.09%	111,977 $25.2 Million
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $2.98 Million - $3.31 Million	12,905 Added 14.23%	103,593 $25.2 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $1.56 Million - $1.73 Million	7,125 Added 8.53%	90,688 $21.9 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $7.29 Million - $8.34 Million	-36,635 Reduced 30.48%	83,563 $18.8 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $2.6 Million - $3.05 Million	-12,256 Reduced 9.25%	120,198 $25.6 Million
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $4.77 Million - $5.29 Million	20,415 Added 18.22%	132,454 $32.3 Million
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $40.1 Million - $46.7 Million	-180,532 Reduced 61.71%	112,039 $27.9 Million
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $39.1 Million - $46.5 Million	180,544 Added 161.16%	292,571 $67.3 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $424,012 - $471,536	1,807 Added 1.64%	112,027 $28.5 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $6.8 Million - $8.34 Million	-34,373 Reduced 23.77%	110,220 $26 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $2.84 Million - $3.77 Million	15,591 Added 12.09%	144,593 $29.3 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $2.1 Million - $2.7 Million	-11,101 Reduced 7.92%	129,002 $31.1 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $1.75 Million - $2.09 Million	-10,041 Reduced 6.69%	140,103 $27.1 Million
Q2 2019 Aug 08, 2019	BUY	$166.7 - $195.41 $9.46 Million - $11.1 Million	56,758 Added 60.78%	150,144 $27.7 Million
Q1 2019 May 09, 2019	BUY	$180.87 - $203.88 $2.73 Million - $3.07 Million	15,069 Added 19.24%	93,386 $17.7 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $820,104 - $957,325	4,597 Added 6.24%	78,317 $15.2 Million
Q3 2018 Nov 09, 2018	BUY	$185.29 - $208.89 $43,357 - $48,880	234 Added 0.32%	73,720 $15.3 Million
Q2 2018 Aug 08, 2018	SELL	$166.05 - $186.51 $189,130 - $212,434	-1,139 Reduced 1.53%	73,486 $13.6 Million
Q1 2018 May 18, 2018	BUY	$169.43 - $198.0 $672,298 - $785,664	3,968 Added 5.62%	74,625 $12.7 Million
Q4 2017 Feb 01, 2018	BUY	$168.79 - $188.59 $208,624 - $233,097	1,236 Added 1.78%	70,657 $12.3 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $11.6 Million - $13.3 Million	69,421	69,421 $12.9 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $178B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.

Account

Cibc World Market Inc. Amgen Inc Transaction History